Targeted treatments for lung cancer
Description: This course describes the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. It also explains the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK inhibitors, angiogenesis inhibitors and immunotherapy.
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
To book, contact: email@example.com or call: 020 7808 2922
View the programme